Comments for

Comment on The FDA Becomes More Social by Russo Partners

Russo Partners — Thu, 12 Jan 2012 16:51:38 +0000

Thank you for your insights. We agree; this is absolutely a step in the right direction and will have beneficial outcomes for patients as well as pharmaceutical and biotechnology companies.

Comment on The FDA Becomes More Social by Jason Boies

Jason Boies — Mon, 09 Jan 2012 20:38:30 +0000

Though it’s a draft at this point, it’s certainly a step in the right direction. The FDA has let it be known they would welcome Pharma companies finding relevant social conversations and adding their voice to the discussion. Even if it means ultimately moving the conversation to more private areas, they recognize the value of drug makers getting involved in online talk surrounding medication and treatments.

Time for Pharma to get social. : )

Cheers

Jason Boies
Radian6 Community Team
@Radian6

Comment on Advanced Cell Technology, Leader in the Human Embryonic Stem Cell Space by Message from Russo Partners

Message from Russo Partners — Tue, 29 Nov 2011 12:47:04 +0000

[...] from Russo Partners Advanced Cell Technology, Leader in the Human Embryonic Stem Cell Space | Advanced Cell Technology, Leader in the Human Embryonic Stem Cell Space Posted on November 28, [...]

Comment on Is Social Media a Friend or Foe for Biotechs? It Depends. by Howard Baldwin

Howard Baldwin — Thu, 25 Aug 2011 17:13:44 +0000

Excellent points here, especially the one relating to the time commitment. There’s nothing worse than a social media site where the last entry is months before. Who’d return to that? On the other hand, there are so many great avenues for social media communication with customers and prospects — you can create a closed LinkedIn group, so you can control who posts (and what); you can start a blog, for a more-personal communicaiton of your company’s goals and strategies. The venues are there, once you establish the message.

Comment on Biopharmaceuticals, Social Media and the FDA – What can we say? by FDA Blogger

FDA Blogger — Sun, 10 Jul 2011 01:15:06 +0000

The FDA has certainly been slow to enter the realm of social media.

Still, as slow as that process may be, the relationship between the FDA and social media is always evolving. For those interested, here’s a related article on what the future may bring for the relationship between social media and the FDA. It’s split into four parts, and may provide a deeper understanding of the issue at hand.

://goo.gl/EBMMK (with ‘http’ in front)

Comment on Symphony of Science by Macco

Macco — Tue, 19 Apr 2011 03:57:42 +0000

That’s way the bstseet answer so far!

Comment on Softening the Downside of Uncertain News: Part 4 by davidschull

davidschull — Thu, 31 Mar 2011 19:43:53 +0000

Let us know if there are topics regarding public relations, the pharmaceutical industry, the biotechnology industry or the drug approval process. We are always open to new questions and ideas.

Comment on Softening the Downside of Uncertain News: Part 4 by Alexandria

Alexandria — Wed, 30 Mar 2011 18:50:56 +0000

I was led to this blog by a posting by a colleague on LinkedIn. I look forward to reading more.

Comment on Simple stories = better outcomes by Wellons Communications

Wellons Communications — Mon, 19 Jul 2010 19:20:03 +0000

This is very true. There is no need for jargon when simple facts get the point across as well.

Comment on ASCO’s Big Reveal by Under Embargo at ADA «

Under Embargo at ADA « — Thu, 17 Jun 2010 19:41:07 +0000

[...] ASCO before it, ADA’s release of the abstracts online affords the market a sneak-peak at the data [...]